NEURO-ONCOLOGY

简称Neuro Oncol
大类医学
小类临床神经病学、肿瘤学
ISSN1522-8517
EISSN1523-5866

最新文献

Super-enhancer-driven TCF4 orchestrates neuroblastoma metastasis by sphingolipid-dependent membrane remodeling and ITGB1-FAK activation

PMID: 416300152026-05-01

Molecular and clinical stratification of astroblastomas: Three distinct fusion-defined groups informing risk-adapted treatment strategies

PMID: 414295682026-04-01

Metabolic profiling defines glioblastoma subtypes with distinct prognoses and therapeutic vulnerabilities

PMID: 414850802026-04-01

A cellular epigenetic classification system for glioblastoma

PMID: 414994532026-04-01

Trastuzumab deruxtecan efficacy, FcRn-facilitated penetration of the blood-tumor barrier, and distribution to tumor cells in HER2+ brain metastasis model systems

PMID: 415019982026-04-01

Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas

PMID: 414601802026-04-01

Improved coping and self-efficacy drive improvements in mood among caregivers of patients with primary malignant brain tumors: Results from an RCT

PMID: 420109352026-04

Exploring the immune environment of glioblastoma in humanized mouse models

PMID: 419130472026-03-30

The 1p/19q co-deletion induces targetable and imageable vulnerabilities in glucose metabolism in oligodendrogliomas

PMID: 418633902026-03-21

Development of a highly differentiated rat brain organoid model for exploring glioblastoma invasion dynamics and therapy

PMID: 412849252026-03-01

A systematic study of molecular diagnosis, treatment, and prognosis in infant-type hemispheric glioma: An individual patient data meta-analysis of 164 patients

PMID: 412067562026-03-01

Reliable cognitive changes the first year following guideline-based treatment of isocitrate dehydrogenase mutated gliomas: A longitudinal multicenter study

PMID: 412069332026-03-01

Bayesian adaptive randomized trial of blended cognitive behavioral therapy for severe fatigue in stable diffuse glioma

PMID: 412080302026-03-01

Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma

PMID: 412339762026-03-01

Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma

PMID: 412067632026-03-01

Phase II study of safusidenib erbumine in patients with chemotherapy- and radiotherapy-naïve isocitrate dehydrogenase 1-mutated WHO grade 2 gliomas

PMID: 412067662026-03-01

Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology

PMID: 412067472026-03-01

DNA methylation profiling predicts postsurgical regrowth in SF1-lineage nonfunctioning pituitary neuroendocrine tumors

PMID: 413691122026-03-01

DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma

PMID: 417615802026-02-28

Stable isotope tracing in human plasma-like medium reveals metabolic and immune modulation of the glioblastoma microenvironment

PMID: 411376582026-02-01